| Value | ₹50.00 Cr |
|---|
NSE filing, NSE: KCK. Summary written from the filing by ALFA Finder's alert engine.
KCK Industries Ltd: key numbers
- Share price
- ₹12.40
- Market cap
- ₹78.87 Cr
- Revenue (annual)
- ₹29.47 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 186.2×Sector 22.8×
- Promoter holding
- 25.55%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KCK Industries Ltd
All →KCK Industries Convertible Warrants
KCK Industries clarified the utilization of issue proceeds (Rs. 50 Crore) for its preferential issue of 2.5 crore convertible warrants following its Extraordinary General Meeting.
- Value
- ₹50.00 Cr
KCK Industries Other Announcement
KCK Industries filed the Regulation 74(5) certificate from its RTA, confirming no physical securities were received for dematerialization during the quarter ended September 30, 2026.
KCK Industries Annual General Meeting
KCK Industries Limited conducted its 13th AGM on September 30, 2026. Shareholders considered the issuance of Convertible Equity Warrants via a Preferential Issue.
KCK Industries Annual General Meeting
KCK Industries issued a corrigendum to its AGM notice, detailing the proposed preferential issue of 2.50 crore convertible equity warrants at Rs. 20 per warrant.
- Value
- ₹50.00 Cr
KCK Industries Annual General Meeting
KCK Industries Limited issued a notice for its 13th AGM on September 30, 2026, covering financial statements, auditor appointment, and a proposed preferential warrant issuance.
KCK Industries Capital Structure Change
KCK Industries Limited approved a preferential issue of 2.50 crore convertible equity warrants at Rs. 20 each, aggregating to Rs. 50 crore.
- Value
- ₹50.00 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr